Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 2Stomach Neoplasms 1Psychological Well-Being 1Pancreatic Neoplasms 1Motor Activity 1Lung Neoplasms 1Liver Neoplasms 1Leiomyoma 1Inflammation 1Esophageal Neoplasms 1Carcinoma, Hepatocellular 1Agnosia 1Abdominal Cancer 1

Interventions

Ketamine 3Sodium Chloride 2Ropivacaine 2Propofol 2Analgesics, Opioid 2Analgesia, Patient-Controlled 2parecoxib 1Tea 1Tapentadol 1Surveys and Questionnaires 1Sevoflurane 1Saline Solution 1Lidocaine 1Ketorolac 1Ibuprofen 1Epinephrine 1Dexamethasone 1Codeine 1Clonidine 1Circumcision, Male 1Celecoxib 1Anesthesia, General 1Acupuncture Therapy 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Agnosia × Tea × Clear all
NCT01438476 2020-02-12

Postoperative Thoracic Epidural Analgesia Versus Intravenous Patient-Controlled Analgesia For Liver and/or Pancreas

M.D. Anderson Cancer Center

Phase 3 Completed
178 enrolled 9 charts
Gastrointestinal

Agnosia, Liver Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡